Please try another search
For the fiscal year ended 31 December 2017, SciGen Limited revenues increased 39% to $40.4M. Net income decreased 14% to $1.8M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income was offset by Other operating expenses increase of 30% to $9.5M (expense), Staff costs increase of 27% to $4.7M (expense), Interest expense increase of 63% to $1.4M (expense).
Period Ending: | Dec 31, 2017 | Jun 30, 2017 | Dec 31, 2016 | Jun 30, 2016 |
---|---|---|---|---|
Total Revenue | 20.44 | 19.95 | 15.72 | 13.42 |
Gross Profit | 9.67 | 9.17 | 7.85 | 7.58 |
Operating Income | 1.66 | 2.57 | 1.7 | 2.37 |
Net Income | 0.1 | 1.67 | 0.49 | 1.57 |
Period Ending: | Dec 31, 2017 | Jun 30, 2017 | Dec 31, 2016 | Jun 30, 2016 |
---|---|---|---|---|
Total Assets | 26.14 | 26.25 | 23.3 | 33.28 |
Total Liabilities | 79.43 | 80 | 79.07 | 89.28 |
Total Equity | -53.28 | -53.76 | -55.77 | -56 |
Period Ending: | Dec 31, 2017 | Jun 30, 2017 | Dec 31, 2016 | Jun 30, 2016 |
---|---|---|---|---|
Period Length: | 12 Months | 6 Months | 12 Months | 6 Months |
Cash From Operating Activities | 1.33 | 1.54 | 1.36 | 0.16 |
Cash From Investing Activities | -0.12 | -0.09 | -0.13 | -0.01 |
Cash From Financing Activities | 0 | 0 | -0.03 | -0.03 |
Net Change in Cash | 1.97 | 1.67 | 1 | 0.06 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review